se of illicit drugs during pregnancy and its risks and outcomes for mother and child - focus cannabisPilot project CaSCH-T1
- Conditions
- DSM-5: substance use disorderF10-F19Mental and behavioural disorders due to psychoactive substance use
- Registration Number
- DRKS00015730
- Lead Sponsor
- Klinikum der Universität MünchenForschungsgruppe Cannabinoide (Ltg. PD Dr. Eva Hoch)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1548
Inclusion Criteria
It is planned to receive completed questionnaires from 200 pregnant women/mothers and 50 medical qualified personnel who treat pregnant women/mothers with substance use.
Exclusion Criteria
Interested participants who do not fit in one of the below defined populations are not eligible for participation at the online survey:
- Pregnant woman or mother
- Physician, midwife or other medical qualified personnel who treats pregnant women/mothers with substance use
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of illicit substance use, especially cannabis, during pregnancy in Germany
- Secondary Outcome Measures
Name Time Method State of knowledge of the target populations about risks and outcome of cannabis use during pregnancy